Table 2. Change in volume of involved limbs, and EORTC-QLQ-C30 and DASH scores after treatment.
| Variables | Before treatment Mean±SD |
After treatment Mean±SD |
p |
| Affected extremity volume (mL) | 3920.1±897.9 | 3297.6±773.1 | <0.001 |
| EORTC-Q30-functional | 72.4±18.6 | 77.4±13.7 | 0.012 |
| EORTC-Q30-symptom | 26.5±12.7 | 20.9±11.3 | <0.001 |
| EORTC-Q30-global health | 58.0±18.3 | 70.7±17.9 | <0.001 |
| DASH | 48.5±30.5 | 39.9±21.9 | 0.016 |
| Jamar | 14.2±6.6 | 14.1±4.7 | 0.897 |
| EORTC-QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire; DASH: Disabilities of the Arm, Shoulder and Hand; SD: Standard deviation. | |||